Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK

Prof. Douglas is an epidemiologist, currently funded by GlaxoSmithKline. He initially studied physiology and completed a PhD in Manchester. Since then, he has spent several years at the UK Medicines & Healthcare Products Regulatory Agency and in the pharmaceutical industry investigating adverse effects of drugs - both in clinical trials and post-marketing. He completed the MSc in epidemiology at LSHTM in 2005.

Prof. Douglas is interested in pharmacoepidemiology, and in particular, how large electronic health record databases can be used to investigate the effects of drugs - both harmful and beneficial. He is exploring methodologies to minimize some of the biases inherent in the research of drug effects, and his main current areas of interest include case-only approaches to study design, the use of non-interventional data to estimate intended treatment effects, quantitative bias analysis, and the application of high dimensional propensity scores in electronic health data.

Ian Douglas teaches "Self-controlled study designs" on Wednesday 18 June 2025.